Drug intelligence / Profile preview

Sniron XT

Development stage
Unknown
Lead developer
SNIG Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Sniron XT is a combination nutritional supplement developed by SNIG Pharmaceuticals Pvt Ltd for the treatment and prevention of iron deficiency anaemia. It contains three active components: ferrous ascorbate, folic acid, and zinc sulphate monohydrate. Ferrous ascorbate provides a highly bioavailable form of elemental iron, which is essential for the synthesis of haemoglobin and the transport of oxygen in the blood. Folic acid, a B-vitamin, is critical for DNA synthesis and the maturation of red blood cells, making it particularly vital during pregnancy to support fetal development and prevent neural tube defects. Zinc sulphate monohydrate provides elemental zinc, an essential trace mineral that supports immune function, protein synthesis, and cellular growth. Sniron XT is indicated for iron supplementation in conditions such as pregnancy, lactation, menorrhagia, and during growth spurts in children and adolescents.

Brand names
Sniron XT
02

Targets

FOLR1 (FRα)

Beyond the preview

Go deeper on Sniron XT.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sniron XT.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call